Evidence map›Paper›PMID 28138373›Full record

ReviewJundishapur journal of microbiology2016

Resistance of

Doblin Sandai, Yasser M Tabana, Ahmad El Ouweini, Ishola Oluwaseun Ayodeji

Abstract readReview
In one paragraph

Review in Jundishapur journal of microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. The roles ofFrontiers in medicine · 2026
    Article
  4. Control ofFuture microbiology · 2025
    Article
  5. Optimization of in vitro Biofilm Growth ofIndian journal of microbiology · 2025
    Article
  6. Article
  7. International journal of molecular and cellular medicine · 2025
    Review
  8. Antifungal Susceptibility andBiomedicines · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. A Putative Role ofMicroorganisms · 2023
    Review
  13. Article
  14. Article
  15. In Silico and In Vitro Analysis of Sulforaphane Anti-Antibiotics (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Article
  18. Fungi-A Component of the Oral Microbiome Involved in Periodontal Diseases.Advances in experimental medicine and biology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Doblin SandaiInfectomics Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia.
Yasser M TabanaInfectomics Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia.
Ahmad El OuweiniSchool of Pharmacy, Lebanese American University, Byblos, Lebanon.
Ishola Oluwaseun AyodejiInfectomics Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectivesThe present work investigated certain aspects of the resistance of

resultsAn ECM was found to provide the infrastructure for biofilm formation, prevent disaggregation, and shield encapsulated

conclusionMature biofilms were found to be much more resistant to antifungal agents and the host immune system than free cells. The factors responsible for high resistance included the complex architecture of biofilms, ECM, increased expression of drug efflux pumps, and metabolic plasticity.

Indexed as

Arsenite Transporting ATPasesBiofilmsCandida albicansFungal Drug ResistanceGlucans

Identifiers

PMID28138373
PMCPMC5240163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.